Thrombotic Thrombocytopenic Purpura Therapy
Research from University of Virginia in thrombotic thrombocytopenic purpura therapy provides new insights
Published in Drug Law Weekly, November 14th, 2006
Investigators publish new data in the report "A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura." According to recent research from the United States, "Photochemical treatment of fresh-frozen plasma (FFP) with amotosalen and ultraviolet (UV) A light (PCT FFP) results in inactivation of a broad spectrum of pathogens while retaining coagulation factor activity, antithrombotic proteins, and von Willebrand factor-cleaving protease (VWF-CP) activity A randomized, controlled, double-blind Phase III trial was conducted with PCT FFP...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2006-11-14)
More Articles from Drug Law Weekly
- Anthrax Vaccine
Safety advocates oppose Pentagon's return to mandatory anthrax vaccination of military personnel - Business & Finance
Caraco Pharmaceutical reports net sales rise 43% - Business & Finance
Enzo Biochem reports results for fiscal 2006 and fourth quarter - Business & Finance
Watson certifies substantial compliance with FTC second request - Business Update
Santarus licenses OTC rights to lower dose immediate-release omeprazole products to Schering - Business Update
Willow Laboratories participates in U.S. Department of Labor's drug-free work week - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
